{"id":13935,"date":"2018-01-15T15:19:43","date_gmt":"2018-01-15T15:19:43","guid":{"rendered":"http:\/\/www.magisterneurociencia.cl\/?p=13935"},"modified":"2018-01-15T15:19:43","modified_gmt":"2018-01-15T15:19:43","slug":"preocupante-avance-de-la-depresion-en-chile","status":"publish","type":"post","link":"https:\/\/magisterneurociencia.uv.cl\/?p=13935","title":{"rendered":"Preocupante avance de la depresi\u00f3n en Chile"},"content":{"rendered":"<span style=\"font-size: 12.16px; text-align: center;\">El 50% de las personas no responde al tratamiento farmacol\u00f3gico.<\/span><!--more-->\n\n<hr id=\"system-readmore\" \/>\n<p style=\"text-align: left;\">\u00a0El neurobi\u00f3logo Alexies Dagnino, director del Laboratorio de Neurobiolog\u00eda del Estr\u00e9s de la Facultad de Ciencias de la Universidad de Valpara\u00edso, afirma que la depresi\u00f3n se adelant\u00f3 tres a\u00f1os en alcanzar la proyecci\u00f3n de la OMS para el a\u00f1o 2020. Ya en el 2017, se posicion\u00f3 como la enfermedad que mayor discapacidad genera en el mundo y entre sus causas destacan los problemas econ\u00f3micos y la desigualdad social, que incrementan la prevalencia de esta patolog\u00eda neuropsiqui\u00e1trica. El ejemplo m\u00e1s claro es Chile, que presenta el PIB m\u00e1s alto de Sudam\u00e9rica y la prevalencia m\u00e1s alta de depresi\u00f3n, ya que el 50% de las personas no responde al tratamiento farmacol\u00f3gico.<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/%20iframe%20src=https:\/\/www.facebook.com\/plugins\/video.php?href=https%3A%2F%2Fwww.facebook.com%2Fuvalpo%2Fvideos%2F10156173425969924%2F&amp;show_text=0&amp;width=560%20width=560%20height=308%20style=border:none;overflow:hidden%20scrolling=no%20frameborder=0%20allowTransparency=true%20allowFullScreen=true\/iframe\">http:\/\/ <iframe loading=\"lazy\" style=\"border: none; overflow: hidden;\" src=\"https:\/\/www.facebook.com\/plugins\/video.php?href=https%3A%2F%2Fwww.facebook.com%2Fuvalpo%2Fvideos%2F10156173425969924%2F&amp;show_text=0&amp;width=560\" width=\"560\" height=\"308\" frameborder=\"0\" scrolling=\"no\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/a><\/p>\n&nbsp;\n\n&nbsp;\n\n&nbsp;\n\n&nbsp;","protected":false},"excerpt":{"rendered":"<p>El 50% de las personas no responde al tratamiento farmacol\u00f3gico.<\/p>\n","protected":false},"author":3,"featured_media":13749,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[182],"tags":[],"_links":{"self":[{"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=\/wp\/v2\/posts\/13935"}],"collection":[{"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13935"}],"version-history":[{"count":0,"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=\/wp\/v2\/posts\/13935\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=\/wp\/v2\/media\/13749"}],"wp:attachment":[{"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/magisterneurociencia.uv.cl\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}